News

Filter

Current filters:

PfizerTorisel

1 to 9 of 15 results

Pfizer says Torisel combo fails in Ph III for kidney cancer

13-08-2012

In a second research disappointment within a matter of days, US drugs behemoth Pfizer (NYSE: PFE) revealed…

AvastinNephrology and HepatologyOncologyPfizerPharmaceuticalResearchTorisel

Pfizer's Torisel fails in Ph III advanced renal cell cancer study

17-05-2012

There was disappointment for global pharma behemoth Pfizer (NYSE: PFE) when it said that the Phase III…

BayerNephrology and HepatologyNexavarOncologyPfizerPharmaceuticalResearchTorisel

"Perverse" NICE again says "No" to new drugs

28-04-2009

John Melville, general manager of Swiss drug major Roche's UK unit, has denounced the National Institute…

AvastinbevacizumabPfizerRocheSunitinib MalateSutentTemsirolimus InjectionToriselWyeth

Sutent cleared for UK kidney cancer patients

30-03-2009

The National Institute for Health and Clinical Excellence (NICE) has recommended the use of global drug…

AspirinAvastinBayerBayerbevacizumabNexavarPfizerRocheSorafenibSunitinib MalateSutentTemsirolimus InjectionToriselWyeth

1 to 9 of 15 results

COMPANY SPOTLIGHT

Menarini

Back to top